Efferocytosis signatures as prognostic markers for revealing immune landscape and predicting immunotherapy response in hepatocellular carcinoma

Efferocytosis signatures as prognostic markers for revealing immune landscape and predicting immunotherapy response in hepatocellular carcinoma

Background: Hepatocellular carcinoma (HCC) is a highly lethal liver cancer with late diagnosis; therefore, the identification of new early biomarkers could help reduce mortality. Efferocytosis, a process in which one cell engulfs another cell, including macrophages, dendritic cells, NK cells, etc.,...

Full description

Bibliographic Details
Main Authors: Ke Xu, Yu Liu, Huiyan Luo, Tengfei Wang
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-06-01
Series:Frontiers in Pharmacology
Subjects:
HCC
efferocytosis
immune
therapy
biomarker
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2023.1218244/full

Similar Items

Similar Items